Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:2010:539519.
doi: 10.1155/2010/539519. Epub 2010 Oct 13.

Tumor antigen cross-presentation and the dendritic cell: where it all begins?

Alison M McDonnell  1 , Bruce W S Robinson, Andrew J Currie
Affiliations

Tumor antigen cross-presentation and the dendritic cell: where it all begins?

Alison M McDonnell et al. Clin Dev Immunol. 2010.

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that are critical for the generation of effective cytotoxic T lymphocyte (CTL) responses; however, their function and phenotype are often defective or altered in tumor-bearing hosts, which may limit their capacity to mount an effective tumor-specific CTL response. In particular, the manner in which exogenous tumor antigens are acquired, processed, and cross-presented to CD8 T cells by DCs in tumor-bearing hosts is not well understood, but may have a profound effect on antitumor immunity. In this paper, we have examined the role of DCs in the cross-presentation of tumor antigen in terms of their subset, function, migration, and location with the intention of examining the early processes that contribute to the development of an ineffective anti-tumor immune response.

PubMed Disclaimer

References

    1. Ochsenbein AF, Sierro S, Odermatt B, et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature. 2001;411(6841):1058–1064. - PubMed
    1. Zinkernagel RM. On cross-priming of MHC class I-specific CTL: rule or exception? European Journal of Immunology. 2002;32(9):2385–2392. - PubMed
    1. Boonman ZFHM, Van Mierlo GJD, Fransen MF, et al. Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction. Journal of Immunology. 2004;172(3):1567–1574. - PubMed
    1. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 1994;264(5161):961–965. - PubMed
    1. McDonnell AM, Prosser AC, van Bruggen I, et al. CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor. European Journal of Immunology. 2010;40(6):1617–1627. - PubMed

Substances